{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:12:21Z","timestamp":1787166741930,"version":"build-2736575974"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The National Institute for Health Research (NIHR) Health Technology Assessment Programme","award":["RRK5908 15\/110\/02"],"award-info":[{"award-number":["RRK5908 15\/110\/02"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0224964","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T13:40:49Z","timestamp":1573825249000},"page":"e0224964","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Acceptability of and treatment preferences for recurrent bacterial vaginosis\u2014Topical lactic acid gel or oral metronidazole antibiotic: Qualitative findings from the VITA trial"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4984-1057","authenticated-orcid":true,"given":"Jocelyn","family":"Anstey Watkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D. C.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhwinder","family":"Thandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Brittain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Kai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,11,15]]},"reference":[{"issue":"1","key":"pone.0224964.ref001","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12879-015-1027-4","article-title":"Making inroads into improving treatment of bacterial vaginosis\u2013striving for long-term cure","volume":"15","author":"CS Bradshaw","year":"2015","journal-title":"BMC infectious diseases"},{"issue":"2","key":"pone.0224964.ref002","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0463.2005.apm1130201.x","article-title":"Bacterial vaginosis\u2013a microbiological and immunological enigma","volume":"113","author":"U Forsum","year":"2005","journal-title":"Apmis"},{"issue":"5","key":"pone.0224964.ref003","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1365-2672.2011.04977.x","article-title":"The aetiology of bacterial vaginosis","volume":"110","author":"Y Turovskiy","year":"2011","journal-title":"Journal of applied microbiology"},{"issue":"1","key":"pone.0224964.ref004","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/sti.2002.002733","article-title":"Managing recurrent bacterial vaginosis","volume":"80","author":"J Wilson","year":"2004","journal-title":"Sexually transmitted infections"},{"key":"pone.0224964.ref005","article-title":"Acute and Recurrent Bacterial Vaginosis","volume":"44","author":"CE Hull","year":"2016","journal-title":"Clinician Reviews"},{"issue":"4","key":"pone.0224964.ref006","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/01.mop.0000170516.35272.45","article-title":"Bacterial vaginosis: many questions-any answers?","volume":"17","author":"RF O'brien","year":"2005","journal-title":"Current opinion in pediatrics"},{"key":"pone.0224964.ref007","author":"D Machado","year":"2016","journal-title":"Bacterial Vaginosis Biofilms: Challenges to Current Therapies and Emerging Solutions"},{"key":"pone.0224964.ref008","volume-title":"UK National Guideline for the management of Bacterial Vaginosis 2012","author":"SP Phillip Hay","year":"2012"},{"issue":"10","key":"pone.0224964.ref009","doi-asserted-by":"crossref","first-page":"e019301","DOI":"10.1136\/bmjopen-2017-019301","article-title":"Probiotics administered intravaginally as a complementary therapy combined with antibiotics for the treatment of bacterial vaginosis: a systematic review protocol","volume":"7","author":"L Ma","year":"2017","journal-title":"BMJ open"},{"issue":"12","key":"pone.0224964.ref010","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/OLQ.0b013e3181e50026","article-title":"Phase 2a study assessing colonization efficiency, safety, and acceptability of Lactobacillus crispatus CTV-05 in women with bacterial vaginosis","volume":"37","author":"A Hemmerling","year":"2010","journal-title":"Sexually transmitted diseases"},{"issue":"1","key":"pone.0224964.ref011","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MRM.0000000000000090","article-title":"Evaluation of probiotic cream by in-vitro tests for treatment of bacterial vaginosis conditions","volume":"28","author":"KV Mogha","year":"2017","journal-title":"Reviews in Medical Microbiology"},{"key":"pone.0224964.ref012","volume-title":"UK National Guideline for the management of Bacterial Vaginosis 2012","author":"NICE","year":"2012"},{"key":"pone.0224964.ref013","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1017\/9781316537398.007","article-title":"Management of Vaginal Discharge","author":"C Armitage","year":"2017","journal-title":"Women's Health in Primary Care"},{"key":"pone.0224964.ref014","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1468-3083.2012.04525.x","article-title":"Adherence to topical treatment in psoriasis: a systematic literature review","volume":"26","author":"S Devaux","year":"2012","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"2","key":"pone.0224964.ref015","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1901\/jaba.1980.13-259","article-title":"Acceptability of alternative treatments for deviant child behavior","volume":"13","author":"AE Kazdin","year":"1980","journal-title":"Journal of Applied Behavior Analysis"},{"issue":"3","key":"pone.0224964.ref016","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/027112149001000304","article-title":"Assessment of treatment acceptability: A review of the literature","volume":"10","author":"RG Miltenberger","year":"1990","journal-title":"Topics in Early Childhood Special Education"},{"key":"pone.0224964.ref017","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/PPA.S24752","article-title":"A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence","volume":"6","author":"CD Barbosa","year":"2012","journal-title":"Patient preference and adherence"},{"issue":"1","key":"pone.0224964.ref018","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12913-017-2031-8","article-title":"Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework","volume":"17","author":"M Sekhon","year":"2017","journal-title":"BMC health services research"},{"issue":"9","key":"pone.0224964.ref019","doi-asserted-by":"crossref","first-page":"e74378","DOI":"10.1371\/journal.pone.0074378","article-title":"The burden of bacterial vaginosis: women\u2019s experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis","volume":"8","author":"JE Bilardi","year":"2013","journal-title":"PloS one"},{"key":"pone.0224964.ref020","author":"ISRCTN","year":"2019","journal-title":"Metronidazole versus lactic acId for treating bacterial vaginosis ISRCTN14161293 registry BMC Springer Nature"},{"key":"pone.0224964.ref021","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-019-3731-7","article-title":"Protocol has been submitted\u2014Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis","author":"Armstrong-Buisseret CB Lindsay","year":"2019","journal-title":"Trials"},{"issue":"9","key":"pone.0224964.ref022","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/ACM.0000000000000388","article-title":"Standards for reporting qualitative research: a synthesis of recommendations","volume":"89","author":"BC O\u2019Brien","year":"2014","journal-title":"Academic Medicine"},{"issue":"2","key":"pone.0224964.ref023","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"V Braun","year":"2006","journal-title":"Qualitative Research in Psychology"},{"issue":"3","key":"pone.0224964.ref024","doi-asserted-by":"crossref","first-page":"e0173637","DOI":"10.1371\/journal.pone.0173637","article-title":"Women view key sexual behaviours as the trigger for the onset and recurrence of bacterial vaginosis","volume":"12","author":"JE Bilardi","year":"2017","journal-title":"PloS one"},{"issue":"1","key":"pone.0224964.ref025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4236\/asm.2017.71001","article-title":"How Vaginal Infections Impact Women's Everyday Life: Women's Lived Experiences of Bacterial Vaginosis and Recurrent Vulvovaginal Candidiasis","volume":"7","author":"A Adolfsson","year":"2017","journal-title":"Advances in Sexual Medicine"},{"issue":"2","key":"pone.0224964.ref026","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1745-7599.2009.00474.x","article-title":"Evidence of African\u2010American women's frustrations with chronic recurrent bacterial vaginosis","volume":"22","author":"SC Payne","year":"2010","journal-title":"Journal of the American Academy of Nurse Practitioners"},{"issue":"8","key":"pone.0224964.ref027","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/QAD.0b013e328346bd3e","article-title":"Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel\u00ae) in sexually active young women (MTN-004)","volume":"25","author":"I McGowan","year":"2011","journal-title":"AIDS (London, England)"},{"issue":"6","key":"pone.0224964.ref028","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/sti.76.6.480","article-title":"Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicide","volume":"76","author":"C Coggins","year":"2000","journal-title":"Sexually Transmitted Infections"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0224964","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T04:49:17Z","timestamp":1576126157000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0224964"}},"subtitle":[],"editor":[{"given":"Wen-Jun","family":"Tu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,11,15]]},"references-count":28,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0224964","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,15]]}}}